Project Description
What is 3D Bioprinting?
Present & Future Perspectives
Wednesday, May 25, 2022
10:00-10:20 am PT / 1:00-1:20 pm ET
Broadcasted live from Los Angeles, US & Turku, Finland

Antti Arjonen, Ph.D.
Chief Science Officer.
Cancer Related Protocols,
Cell Imaging Technologies,
and BioInks.
